Search Results - "Kévin Bigaut"

Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society by Collongues, Nicolas, Durand-Dubief, Françoise, Lebrun-Frenay, Christine, Audoin, Bertrand, Ayrignac, Xavier, Bensa, Caroline, Bigaut, Kévin, Bourre, Bertrand, Carra-Dallière, Clarisse, Ciron, Jonathan, Defer, Gilles, Kwiatkowski, Arnaud, Leray, Emmanuelle, Maillart, Elisabeth, Marignier, Romain, Mathey, Guillaume, Morel, Nathalie, Thouvenot, Eric, Zéphir, Hélène, Boucher, Julie, Boutière, Clémence, Branger, Pierre, Da Silva, Angélique, Demortière, Sarah, Guillaume, Maxime, Hebant, Benjamin, Januel, Edouard, Kerbrat, Anne, Manchon, Eric, Moisset, Xavier, Montcuquet, Alexis, Pierret, Chloé, Pique, Julie, Poupart, Julien, Prunis, Chloé, Roux, Thomas, Schmitt, Perrine, Androdias, Géraldine, Cohen, Mikael

“…Background: Epidemiological data reveal that 45% of persons with multiple sclerosis (PwMS) in France are more than 50 years. This population more than 50 is…”
Get full text

A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases by Pisella, Lucie Isoline, Fernandes, Sara, Solé, Guilhem, Stojkovic, Tanya, Tard, Céline, Chanson, Jean-Baptiste, Bouhour, Françoise, Salort-Campana, Emmanuelle, Beaudonnet, Guillemette, Debergé, Louise, Duval, Fanny, Grapperon, Aude-Marie, Masingue, Marion, Nadaj-Pakleza, Aleksandra, Péréon, Yann, Audic, Frédérique, Behin, Anthony, Friedman, Diane, Magot, Armelle, Noury, Jean-Baptiste, Souvannanorath, Sarah, Wahbi, Karim, Antoine, Jean-Christophe, Bigaut, Kévin, Camdessanché, Jean-Philippe, Cintas, Pascal, Debs, Rabab, Espil-Taris, Caroline, Kremer, Laurent, Kuntzer, Thierry, Laforêt, Pascal, Laugel, Vincent, Mallaret, Martial, Michaud, Maud, Nollet, Sylvain, Svahn, Juliette, Vicart, Savine, Villar-Quiles, Rocio Nur, Desguerre, Isabelle, Adams, David, Segovia-Kueny, Sandrine, Merret, Géraldine, Hammouda, Elhadi, Molon, Annamaria, Attarian, Shahram

“…Due to their health condition, patients with neuromuscular diseases (NMD) are at greater risk of developing serious complications with COVID-19. The objective…”
Get full text

The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use by Birmpili, Dafni, Charmarke Askar, Imane, Bigaut, Kévin, Bagnard, Dominique

“…Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system which is characterized by demyelinating lesions and axonal damage…”
Get full text

A rise in cases of nitrous oxide abuse: neurological complications and biological findings by Einsiedler, Maximilian, Voulleminot, Paul, Demuth, Stanislas, Kalaaji, Pauline, Bogdan, Thomas, Gauer, Lucas, Reschwein, Cécile, Nadaj-Pakleza, Aleksandra, de Sèze, Jérôme, Kremer, Laurent, Schroder, Ivana, Bigaut, Kévin

“…Background The recent lockdown due to the COVID-19 pandemic has been linked to a higher incidence of psychiatric manifestations and substance abuse. The…”
Get full text

Good therapeutic response to infliximab in a case of Susac syndrome refractory to immunotherapies including tocilizumab by Demuth, Stanislas, Bogdan, Thomas, Kremer, Laurent, Lanotte, Livia, Collongues, Nicolas, de Seze, Jérôme, Bigaut, Kévin

Get full text

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study by Bigaut, Kévin, Kremer, Laurent, Fabacher, Thibaut, Ahle, Guido, Goudot, Mathilde, Fleury, Marie, Gaultier, Claude, Courtois, Sylvie, Collongues, Nicolas, de Seze, Jérôme

“…Background Exit strategy after natalizumab cessation in multiple sclerosis (MS) is a crucial point because the risk of disease reactivation is high during this…”
Get full text

Multiple sclerosis diagnostic criteria: From poser to the 2017 revised McDonald criteria by de Seze, Jérôme, Bigaut, Kévin

Get full text

Anti-CD20 immunotherapy in progressive multiple sclerosis: 2-year real-world follow-up of 108 patients by Einsiedler, Maximilian, Kremer, Laurent, Fleury, Marie, Collongues, Nicolas, De Sèze, Jérôme, Bigaut, Kévin

“…Background Anti-CD20 monoclonal antibodies are recently introduced treatments in progressive MS and real-world data are lacking. Objective The aim of this…”
Get full text

Guillain-Barré syndrome related to SARS-CoV-2 infection by Bigaut, Kévin, Mallaret, Martial, Baloglu, Seyyid, Nemoz, Benjamin, Morand, Patrice, Baicry, Florent, Godon, Alexandre, Voulleminot, Paul, Kremer, Laurent, Chanson, Jean-Baptiste, de Seze, Jérôme

Get full text

Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort by Bigaut, Kévin, Fabacher, Thibaut, Kremer, Laurent, Ongagna, Jean-Claude, Kwiatkowski, Arnaud, Sellal, François, Ferriby, Didier, Courtois, Sylvie, Vermersch, Patrick, Collongues, Nicolas, Zéphir, Hélène, De Seze, Jérôme, Outteryck, Olivier

“…Background: Data are needed on long-term effect of natalizumab (NTZ) in relapsing-remitting multiple sclerosis (RRMS). Objectives: To evaluate the time of…”
Get full text

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD) by Bigaut, Kévin, Achard, Sophie, Hemmert, Céline, Baloglu, Seyyid, Kremer, Laurent, Collongues, Nicolas, De Sèze, Jérôme, Kremer, Stéphane

“…The relation between brain functional connectivity of patients with neuromyelitis optica spectrum disorder (NMOSD) and the degree of disability remains…”
Get full text

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study by Bigaut, Kévin, Kremer, Laurent, Fabacher, Thibaut, Lanotte, Livia, Fleury, Marie-Celine, Collongues, Nicolas, de Seze, Jerome

“…To compare the humoral response after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with multiple sclerosis (MS) receiving…”
Get full text

Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy by Krief, Nolwenn, Gabriel, René, Cauquil, Cécile, Adams, David, Fargeot, Guillaume, Maisonobe, Thierry, Osman, David, Schmidt, Matthieu, Chanson, Jean-Baptiste, Bigaut, Kevin, Sole, Guilhem, Tard, Céline, Nicolas, Guillaume, Pereon, Yann, Aure, Karine, Lagrange, Emmeline, Lefilliatre, Mathilde, Labeyrie, Marc-Antoine, Echaniz-Laguna, Andoni

“…Background Guillain–Barre syndrome (GBS) is an acute inflammatory polyradiculoneuropathy rarely observed during pregnancy. Methods In this retrospective study,…”
Get full text

Confrontation anatomoclinique – Syndrome pyramidal, ataxie cérébelleuse et nystagmus vertical chez un homme de 47 ans – Observation by Bigaut, Kévin

“…Il s’agit d’un homme de 47 ans aux antécédents de migraine sans aura et de névralgie d’Arnold, chez qui est apparu sur quelques jours des troubles sensitifs…”
Get full text

An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies by Brun, Susana, Schall, Nicolas, Bonam, Srinivasa Reddy, Bigaut, Kévin, Mensah-Nyagan, Ayikoe-Guy, de Sèze, Jérôme, Muller, Sylviane

“…Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune disease of the peripheral nerves evolving with diffuse sensory and motor…”
Get full text

Early use of high efficacy therapies in pediatric forms of relapsing-remitting multiple sclerosis: A real-life observational study by Moreau, Augustin, Kolitsi, Ioanna, Kremer, Laurent, Fleury, Marie, Lanotte, Livia, Sellal, François, Gaultier, Claude, Ahle, Guido, Courtois, Sylvie, Fickl, Andreas, Mostoufizadeh, Sohrab, Dentel, Christel, Collongues, Nicolas, de Seze, Jérôme, Bigaut, Kévin

“…•Pediatric MS patients have a more inflammatory disease course than adults.•Patients under high-efficacy therapy from start had fewer relapses than patients…”
Get full text

How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP) by Bigaut, Kévin, Cohen, Mikaël, Durand-Dubief, Françoise, Maillart, Elisabeth, Planque, Evelyne, Zephir, Hélène, Lebrun-Frenay, Christine, de Seze, Jérôme

“…•No recommendations are available on switching disease-modifying treatments in multiple sclerosis•The French Multiple Sclerosis Society proposes guidelines on…”
Get full text

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study by Levraut, Michael, Laurent-Chabalier, Sabine, Ayrignac, Xavier, Bigaut, Kévin, Rival, Manon, Squalli, Sanae, Zéphir, Hélène, Alberto, Tifanie, Pekar, Jean-David, Ciron, Jonathan, Biotti, Damien, Puissant-Lubrano, Bénédicte, Camdessanché, Jean-Philippe, Tholance, Yannick, Casez, Olivier, Toussaint, Bertrand, Marion, Jeanne, Moreau, Thibault, Lakomy, Daniela, Thomasset, Audrey, Maillart, Elisabeth, Sterlin, Delphine, Maurousset, Aude, Rocher, Auriane, Laplaud, David Axel, Bigot-Corbel, Edith, Bertho, Pierre-Olivier, Pelletier, Jean, Boucraut, Joseph, Labauge, Pierre, Vincent, Thierry, De Sèze, Jérôme, Jahn, Isabelle, Seitz-Polski, Barbara, Thouvenot, Eric, Lebrun-Frenay, Christine

“…BACKGROUND AND OBJECTIVESKappa free light chains (KFLC) seem to efficiently diagnose MS. However, extensive cohort studies are lacking to establish consensus…”
Get full text

Nos étudiants sont-ils neurophobes ? Image de la neurologie chez les étudiants de médecine de Strasbourg by Bigaut, Kévin, Reschwein, Cécile

“…Terme employé pour la première fois en 1994, la neurophobie est la peur de la neurologie, liée aux difficultés des étudiants pour appliquer leurs connaissances…”
Get full text

Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort by Pelle, Juliette, Briant, Anais R., Branger, Pierre, Derache, Nathalie, Arnaud, Charlotte, Lebrun-Frenay, Christine, Cohen, Mikael, Mondot, Lydiane, De Seze, Jerome, Bigaut, Kevin, Collongues, Nicolas, Kremer, Laurent, Ricard, Damien, Bompaire, Flavie, Ohlmann, Charlotte, Sallansonnet-Froment, Magali, Ciron, Jonathan, Biotti, Damien, Pignolet, Beatrice, Parienti, Jean-Jacques, Defer, Gilles

“…Introduction Natalizumab, a therapy for relapsing–remitting multiple sclerosis (RRMS), is associated with a risk of progressive multifocal leukoencephalopathy…”
Get full text